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Our debaters have argued their preferred approaches for
younger patients with symptomatic peripheral arterial disease
(PAD) and have included such issues as procedure-related mor-
bidity, patency and durability, reinterventions, and life expec-
tancy. A similar discussion could occur regarding younger pa-
tients with abdominal aortic aneurysms and the comparative
value of an endovascular or open repair. However, this analogy
is not entirely appropriate. Whereas durability of the repair and
need for reintervention is especially relevant in these young
aneurysm patients with their longer life expectancies, young
PAD patients represent a group with more aggressive systemic
atherosclerotic disease. At best, these younger patients can
expect an absolute life expectancy similar to their older symp-
tomatic PAD counterparts.1
The early presentation of symptomatic PAD is a marker of
coinciding premature atherosclerotic disease in the coronary
and carotid circulations. Medical therapy and risk factor modi-
fication are especially vital in these patients, regardless of the
operative or interventional approach used for their PAD. Spe-
cific risk factors, including lipoprotein(a) level 30 mg/dL,
have been identified as risk factors for premature PAD, espe-
cially in men.2 Despite adequate medical therapy and diabetes
management, these patients are at increased risk for major
cardiovascular events. Recent evidence would suggest that
young women with PAD are especially susceptible to cardiovas-hD, London, Ontario, Canada; and Poitiers, France
Along with a more aggressive form of systemic atherosclerotic
isease, young PAD patients appear to be predisposed to multiple
rocedures or interventions. A review of younger men with symp-
omatic PAD found 40% required multiple interventions because
f progression of their disease or bypass graft failure.1 Predictors of
reatment failure have been investigated recently. In a cohort of
hinese patients, 38% of young PAD patients had thrombophilia
hat proved to be an independent predictor of graft thrombosis and
ajor amputation at 30 days and of decreased patency and limb
alvage after 1 year.4
Young patients with symptomatic PAD represent an espe-
ially challenging group for vascular surgeons. As with older
atients, they represent a population with aggressive systemic
therosclerosis and a somewhat limited life expectancy. Aggres-
ive medical therapy and risk factor modification are mandatory,
nd the choice of bypass or endovascular therapy for their PAD
eeds to reflect this limited life expectancy. In PAD patients of
ll ages in the Bypass vs Angioplasty in Severe Ischaemia of the
eg (BASIL) trial,5 bypass with adequate great saphenous vein
as superior to angioplasty in those with a life expectancy 2
ears.
Regardless, the optimal therapy should limit periprocedural
orbidity and mortality, should be durable, require few—if any—
einterventions, and be successful in resolving symptoms and avoid-
ng major amputation. These are complex decisions and should be
ndividualized to the patient’s symptoms, anatomy, and comorbidi-
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Volume 56, Number 2 Forbes and Ricco 555ties, and require consideration of both open and endovascular thera-
pies by vascular surgeons.
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